Lab scientists at Analog/Sci have been reviewing the updates to Health Canada's Cosmetic Ingredient Hotlist to keep abreast for our Canadian company clients. Canadian cosmetic manufacturers have been provided notice that Health Canada will be updating the reviews of the cosmetic ingredients Hotlist. The Hotlist serves as an administrative tool that provides the regulatory statements about ingredients that may violate the FDA or Cosmetic Regulations (CR) guidelines. Some ingredients on the Hotlist may be permitted in cosmetic formulations if they are used in specific percentage amounts and the manufacturer strictly follows Good Manufacturing Processes.
The CIH is a science based report that is reviewed and updated periodically (i.e. when new scientific data becomes available). Health Canada can take actions at any time to enforce the FDA and CR requirements even if a material is not on the Hotlist. Evidence based data, advise, opinions, decisions and reviews of scientific journals are made by national and international regulatory governances and expert panel groups, to conclude on changes or updates to the Hotlist. The last update to the Hotlist was in December 2019.
Current shelved products could be impacted by the possible updates, and manufacturers will need to begin to think about the necessary changes to product formulations, distribution and sale.
Canada's Chemical Management Plan (CMP) shares information with the Canadian Environmental Act-1999 and will be reviewing the following additions
Other materials that continue to be under review which are subject to regularly offered updates and are currently on the Canada Health Cosmetic Ingredient Hotlist are talc, benzophenone, boric acid, Malachite green, Solvent Violet 13 and chlorocresol.
Prohibited materials are not permitted to be present in cosmetic products sold in Canada. Restricted ingredients are permitted, only if the exact amount permitted by law, is used in the formulation and official documentation must be provided with detailed ingredient levels and methods used in manufacturing.
Comments will be approved before showing up.
Currently, more than 50 countries have adopted medicinal cannabis programmes while Canada, Uruguay and 15 US states have legalized its recreational use, with Mexico and Luxembourg having political debates as to whether to follow that path. - UN News & UN CND (Commission on Narcotic Drugs)
This market shift toward the wider cultural acceptance of therapeutic cannabis is finding consumer brands rushing to market to fulfil marketplace demands with unsufficient scientific alignment. The reality is, and many science institutions (FDA, UK Commission, WHO) have agreed, that there has not been sufficient testing, length of study, nor broad-scope subjective data collected on longterm human effects that is available to us today.
Innovation Superclusters are engines of economic growth. Built around industries of the future, Superclusters can accelerate transformation and drive system-level innovation. The Canadian Cosmetic Cluster is an internationally recognized hub that participates in global trade initiatives and provides service to local and international cosmetic companies. Collaborating, developing, supporting with academia, capital and national policy, Canada can become a centre for global Superclusters.
Sign up for 50% off your VIP purchase now!
Sign Up for VIP Passport e-Updates & Get 50% off first purchase now!